Bulletin
Investor Alert

Cerecor Inc.

NAS: CERC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 10, 2019, 4:00 p.m.

/zigman2/quotes/201368871/composite

$

3.84

Change

0.00 0.00%

Volume

Volume 216

Quotes are delayed by 20 min

/zigman2/quotes/201368871/composite

Today's close

$ 3.72

$ 3.84

Change

+0.12 +3.23%

Day low

Day high

$3.68

$4.01

Open

52 week low

52 week high

$2.71

$7.65

Open

Peter S. Greenleaf

Peter S. Greenleaf is a businessperson who has been at the helm of 7 different companies and presently occupies the position of Chairman of BioDelivery Sciences International, Inc. and Chairman at Maryland Venture Fund. He is also on the board of 5 other companies.

In his past career he held the position of President, Chief Executive Officer & Director at Histogenics Corp., Principal at Hallmark Cards, Inc., Chairman & Chief Executive Officer for Sucampo Pharmaceuticals, Inc., President at MedImmune LLC, President for MedImmune Ventures, Inc., Principal at Roche Diagnostics Corp., Principal at US Healthcare, Inc. and VP-US Gastroenterology Commercial Group at Centocor, Inc.

Mr. Greenleaf received an undergraduate degree from Western Connecticut State University and an MBA from St. Joseph's University.

Transactions

Date Shares Transaction Value
05/24/2019 300,000   0
05/18/2018 12,500   Acquisition at $3.98 per share. 49,750
03/27/2018 400,000   Award at $0 per share. 0

Officers and Executives

Dr. Simon C. Pedder
Executive Chairman
Mr. Joseph M. Miller
Secretary, Chief Financial & Accounting Officer
Dr. Perry Calias
Chief Scientific Officer
Dr. Bernadine Heather Fraser
VP-Clinical Operations & Project Management
Mr. Peter S. Greenleaf
Director
Dr. Uli Alf Hacksell
Director
Mr. Steven Joseph Boyd
Director
Mr. James A. Harrell
Chief Commercial Officer
Mr. Keith W. Schmidt
Independent Director
Mr. Phil Gutry
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Link to MarketWatch's Slice.